Medical Care Technologies Inc. Expands AI Platform to Detect Glaucoma and Cataracts

Rhea-AI Summary

Medical Care Technologies (OTC:MDCE) has enhanced its AI Facial Health Risk Estimator platform to include detection capabilities for glaucoma and cataracts. The expanded platform now analyzes high-resolution facial and ocular images to identify corneal opacity, lens clouding, and early optic nerve changes.

The integration creates a comprehensive preventive care solution by combining eye health monitoring with existing systemic and dermatological metrics. CEO Marshall Perkins emphasized the platform's holistic approach to early detection of vision-threatening conditions.

Positive

• Integration of glaucoma and cataract detection expands product capabilities
• Platform enhancement addresses major global vision health issues
• Creation of a more comprehensive preventive care solution

Negative

• None.

MESA, ARIZONA / ACCESS Newswire / September 25, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) announced that its AI Facial Health Risk Estimator now includes early detection and monitoring of glaucoma and cataracts, two leading causes of vision loss globally.

Using high-resolution facial and ocular image analysis, the platform detects:

• Corneal opacity and lens clouding for cataracts

• Early optic nerve changes and other glaucoma biomarkers

This integration allows patients and clinicians to monitor eye health alongside systemic and dermatological metrics, creating a comprehensive preventive care solution.

"Our AI platform is holistic," said Marshall Perkins, CEO of MDCE. "Detecting vision-threatening conditions early preserves sight and advances global standards in preventive medicine."

Company Websites: www.medicalcaretechnologies.com | www.mdcestock.com

About Medical Care Technologies Inc.
Medical Care Technologies Inc. (OTC PINK: MDCE) leverages AI for early disease detection across dermatology, neurology, ocular, and systemic health domains.

Safe Harbor Statement:
This release contains forward-looking statements; actual results may differ due to risks and uncertainties.

Contact:

Investor Relations
Medical Care Technologies Inc.
info@infiniteauctions.com
Website: www.mdcestock.com

SOURCE: Medical Care Technologies Inc. (OTC PINK:MDCE)

View the original press release on ACCESS Newswire

FAQ

What new features did Medical Care Technologies (MDCE) add to its AI platform in September 2025?

MDCE added glaucoma and cataract detection capabilities to its AI Facial Health Risk Estimator platform, enabling early detection through facial and ocular image analysis.

How does MDCE's AI platform detect glaucoma and cataracts?

The platform uses high-resolution facial and ocular image analysis to detect corneal opacity, lens clouding for cataracts, and early optic nerve changes for glaucoma.

What is the purpose of MDCE's AI Facial Health Risk Estimator?

The platform provides comprehensive preventive care by monitoring eye health alongside systemic and dermatological metrics to detect vision-threatening conditions early.

Who is the CEO of Medical Care Technologies (MDCE)?

Marshall Perkins is the CEO of Medical Care Technologies (MDCE).